GT Biotech Fund, LP — Form D/A

GT Biotech Fund, LP of Memphis, TN, a pooled investment fund, filed a Form D amendment with the SEC on 2023-07-28. $217.0M was reported sold. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
David G EastExecutive OfficerMemphis, TN
William E PickensExecutive OfficerMemphis, TN
Justin T RikardExecutive OfficerMemphis, TN
Michael J DouglassExecutive OfficerMemphis, TN
Justin L RikardExecutive OfficerMemphis, TN
Darren T KearnsExecutive OfficerMemphis, TN
n/a Gerber/Taylor Management LLCExecutive OfficerMemphis, TN
n/a Gerber/Taylor Management LLCPromoterMemphis, TN
Simone T MeeksExecutive OfficerMemphis, TN
Ryan E GibbsExecutive OfficerMemphis, TN
Mary C CornpropstExecutive OfficerMemphis, TN
Charles C GerberExecutive OfficerMemphis, TN
n/a Gerber/Taylor Management CompanyPromoterMemphis, TN
Justin L. RikardRelated PersonMemphis, TN
Simone T. MeeksRelated PersonMemphis, TN
Ryan E. GibbsRelated PersonMemphis, TN
Mary C. CornpropstRelated PersonMemphis, TN
Michael J. DouglassRelated PersonMemphis, TN
Darren KearnsRelated PersonMemphis, TN

Other filings by this issuer (8)

FiledFormOfferingSold
2026-07-29D/A$233.5M
2025-07-29D/A$229.3M
2024-07-29D/A$221.6M
2022-07-29D/A$194.6M
2021-07-30D/A$104.4M
2021-03-16D/A$61.2M
2020-04-13D/A$16.0M
2020-03-16D

More